8188104 May 17, 2029 — Yes Yes U-1636 USE OF DASABUVIR TO INHIBIT VIRAL REPLICATION FOR THE TREATMENT OF HCV INFECTION. — 8420596 Apr 10, 2031 — Yes Yes — — 8466159 Sep 4, 2032 — — — U-1637 TREATMENT OF HCV INFECTION USING PARITAPREVIR, OMBITASVIR, RITONAVIR, AND DASABUVIR WITH RIBAVIRIN. — 8492386 Sep 4, 2032 — — — U-1840 TREATMENT OF HCV INFECTION USING PARITAPREVIR, OMBITASVIR, RITONAVIR, AND DASABUVIR, WITHOUT RIBAVIRIN — 8501238 Sep 17, 2028 — Yes Yes U-1636 USE OF DASABUVIR TO INHIBIT VIRAL REPLICATION FOR THE TREATMENT OF HCV INFECTION. — 8642538 Sep 10, 2029 — Yes Yes U-1638 TREATMENT OF HCV INFECTION USING PARITAPREVIR — 8680106 Sep 4, 2032 — — — U-1637 TREATMENT OF HCV INFECTION USING PARITAPREVIR, OMBITASVIR, RITONAVIR, AND DASABUVIR WITH RIBAVIRIN. — 8685984 Sep 4, 2032 — — — U-1840 TREATMENT OF HCV INFECTION USING PARITAPREVIR, OMBITASVIR, RITONAVIR, AND DASABUVIR, WITHOUT RIBAVIRIN — 8686026 Jun 9, 2031 — — Yes — — 8691938 Apr 13, 2032 — Yes Yes — — 9006387 Jun 10, 2030 — — — U-1687 TREATMENT OF HCV INFECTION USING OMBITASVIR — 9044480 Apr 10, 2031 — — — U-1638 TREATMENT OF HCV INFECTION USING PARITAPREVIR — 9139536 Nov 9, 2028 — — — U-1753 TREATMENT OF HCV INFECTION USING DASABUVIR — 9333204 Jan 2, 2035 — — Yes U-1889 TREATMENT OF HCV INFECTION USING DASABUVIR/OMBITASVIR/PARITAPREVIR/RITONAVIR FIXED DOSE COMBINATION — 9744170 Jan 2, 2035 — — Yes U-1889 TREATMENT OF HCV INFECTION USING DASABUVIR/OMBITASVIR/PARITAPREVIR/RITONAVIR FIXED DOSE COMBINATION — 10105365 Jan 2, 2035 — — Yes U-1889 TREATMENT OF HCV INFECTION USING DASABUVIR/OMBITASVIR/PARITAPREVIR/RITONAVIR FIXED DOSE COMBINATION — 10201541 May 17, 2032 — — Yes — — 10201584 May 17, 2032 — — — U-1889 TREATMENT OF HCV INFECTION USING DASABUVIR/OMBITASVIR/PARITAPREVIR/RITONAVIR FIXED DOSE COMBINATION —